Relationship between Leukopenia and Intercellular Adhesion Molecules in Graves' Disease

Area of Science:

• Endocrinology
• Immunology
• Hematology

Background:

• Graves' disease (GD) is an autoimmune disorder affecting the thyroid.
• Leukopenia, a reduced white blood cell count, can occur in GD patients.
• Intercellular adhesion molecules (ICAMs) like sICAM-1 and E-selectin play roles in immune responses.

Purpose of the Study:

• To investigate the relationship between leukopenia and levels of soluble intercellular adhesion molecule-1 (sICAM-1) and E-selectin in Graves' disease.
• To assess the effect of glucocorticoid treatment on these markers in GD patients with leukopenia.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure serum sICAM-1 and E-selectin levels.
• Blood samples were collected from GD patients with normal leukocytes and those with leukopenia.
• Measurements were repeated in leukopenic GD patients after prednisone treatment.

Main Results:

• E-selectin levels were significantly higher in GD patients with leukopenia compared to those with normal leukocytes.
• E-selectin levels decreased significantly after glucocorticoid (prednisone) treatment.
• No significant change was observed in sICAM-1 levels.
• Leukocyte count was negatively correlated with E-selectin levels.

Conclusions:

• E-selectin appears to play a significant role in Graves' disease associated with leukopenia.
• Glucocorticoids, such as prednisone, can reduce E-selectin levels.
• E-selectin modulation represents a potential therapeutic strategy for managing leukopenia in Graves' disease.